Soumya D Chakravarty Selected Research

Soumya D Chakravarty Research Topics

Disease

38	Psoriatic Arthritis 02/2024 - 01/2019
19	Psoriasis (Pustulosis Palmaris et Plantaris) 02/2024 - 01/2018
9	Arthritis (Polyarthritis) 02/2024 - 01/2020
7	Pain (Aches) 02/2024 - 01/2020
7	Infections 10/2023 - 01/2019
6	Ankylosing Spondylitis 12/2023 - 11/2020
6	Rheumatoid Arthritis 08/2022 - 07/2013
4	Sacroiliitis 12/2023 - 10/2021
4	Tuberculosis (Tuberculoses) 10/2023 - 02/2007
3	Opportunistic Infections (Opportunistic Infection) 10/2023 - 01/2021
3	Crohn Disease (Crohn's Disease) 10/2023 - 01/2019
3	Skin Diseases (Skin Disease) 01/2023 - 09/2022
3	Fatigue 12/2022 - 01/2020
3	Inflammation (Inflammations) 09/2022 - 03/2008
3	Necrosis 01/2021 - 01/2019
2	Neoplasms (Cancer) 10/2023 - 01/2022
2	Joint Diseases (Joint Disease) 10/2023 - 01/2023
2	Axial Spondyloarthritis 08/2023 - 01/2023
2	Spondylitis 08/2023 - 01/2020
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2021 - 10/2019
2	Granuloma 10/2012 - 03/2008
1	Ulcerative Colitis 10/2023
1	Back Pain (Backache) 01/2023
1	Ankylosis 12/2022
1	Chronic Disease (Chronic Diseases) 01/2022
1	Rheumatic Diseases (Rheumatism) 11/2020
1	Multiple Sclerosis 10/2012
1	Sarcoidosis (Schaumann Disease) 10/2012
1	Chronic Urticaria 12/2011
1	Latent Tuberculosis 03/2008

Drug/Important Bio-Agent (IBA)

24	guselkumabIBA 02/2024 - 01/2021
10	golimumab FDA Link 12/2022 - 01/2020
8	Tumor Necrosis Factor InhibitorsIBA 01/2024 - 01/2019
8	Ustekinumab (CNTO 1275)FDA Link 01/2023 - 01/2019
6	Interleukin-23 (Interleukin 23)IBA 01/2024 - 01/2022
6	Monoclonal AntibodiesIBA 12/2022 - 11/2020
5	InterleukinsIBA 01/2024 - 01/2021
5	Immunoglobulin A (IgA)IBA 01/2024 - 01/2022
5	Interleukin-17 (Interleukin 17)IBA 01/2023 - 10/2019
4	ametantrone (HAQ)IBA 02/2024 - 09/2022
4	Antirheumatic Agents (DMARD)IBA 02/2024 - 01/2021
4	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2023
4	Methotrexate (Mexate)FDA LinkGeneric 10/2023 - 01/2019
3	Prostaglandins AIBA 12/2023 - 01/2019
3	Adalimumab (Humira)FDA Link 11/2023 - 01/2019
3	Interleukin-12 (IL 12)IBA 01/2023 - 01/2020
3	HLA-B27 Antigen (HLA B27 Antigen)IBA 01/2023 - 01/2020
3	Interleukin-23 Subunit p19IBA 12/2022 - 01/2021
3	Infliximab (Remicade)FDA Link 08/2022 - 01/2019
2	omega-Chloroacetophenone (Mace)IBA 10/2023 - 01/2022
2	CytokinesIBA 01/2023 - 01/2023
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 01/2019
2	C-Reactive ProteinIBA 10/2021 - 01/2021
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2020 - 03/2008
2	Etanercept (Enbrel)FDA Link 01/2020 - 01/2019
1	O,O-diisopropyl-S-benzylthiophosphate (IBP)IBA 01/2023
1	risankizumabIBA 01/2023
1	Interleukin-10 (Interleukin 10)IBA 01/2023
1	HLA-B38 AntigenIBA 01/2023
1	HLA-B13 AntigenIBA 01/2023
1	HLA-B57 antigenIBA 01/2023
1	Antigen-Antibody Complex (Immune Complex)IBA 12/2022
1	AS 8IBA 09/2021
1	Certolizumab Pegol FDA Link 01/2020
1	AntigensIBA 01/2020
1	Phosphodiesterase 4 InhibitorsIBA 10/2019
1	Immunologic Factors (Immunomodulators)IBA 01/2019
1	SteroidsIBA 01/2018
1	Phosphotransferases (Kinase)IBA 07/2013
1	Interferon-betaIBA 10/2012
1	Interferon Type IIBA 10/2012
1	Rituximab (Mabthera)FDA Link 12/2011
1	IgE Receptors (Fc epsilon RI)IBA 12/2011
1	AutoantibodiesIBA 12/2011
1	Chemokine ReceptorsIBA 02/2007

Therapy/Procedure

8	Therapeutics 08/2023 - 03/2008
3	Biological Therapy 12/2022 - 01/2019
1	Subcutaneous Injections 10/2023
1	Time-to-Treatment 01/2023
1	Activities of Daily Living (ADL) 03/2021
1	Injections 01/2020